Adrienne C. Lahti - Publications

Affiliations: 
Psychiatry and Behavioral Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
PET, fMRI, MR Spectroscopy, schizophrenia, bipolar disorder, psychotropic drugs, brain function

117 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Goodman AM, Allendorfer JB, Blum AS, Bolding MS, Correia S, Ver Hoef LW, Gaston TE, Grayson LE, Kraguljac NV, Lahti AC, Martin AN, Monroe WS, Philip NS, Tocco K, Vogel V, et al. White matter and neurite morphology differ in psychogenic nonepileptic seizures. Annals of Clinical and Translational Neurology. PMID 32991786 DOI: 10.1002/acn3.51198  1
2020 Gawne TJ, Overbeek GJ, Killen JF, Reid MA, Kraguljac NV, Denney TS, Ellis CA, Lahti AC. A multimodal magnetoencephalography 7 T fMRI and 7 T proton MR spectroscopy study in first episode psychosis. Npj Schizophrenia. 6: 23. PMID 32887887 DOI: 10.1038/s41537-020-00113-4  1
2020 Nelson EA, Kraguljac NV, Maximo JO, Briend F, Armstrong W, Ver Hoef LW, Johnson V, Lahti AC. Hippocampal Dysconnectivity and Altered Glutamatergic Modulation of the Default Mode Network: A Combined Resting-State Connectivity and Magnetic Resonance Spectroscopy Study in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32684484 DOI: 10.1016/j.bpsc.2020.04.014  1
2020 Briend F, Nelson EA, Maximo O, Armstrong WP, Kraguljac NV, Lahti AC. Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis. Translational Psychiatry. 10: 137. PMID 32398671 DOI: 10.1038/s41398-020-0812-z  1
2020 Briend F, Armstrong WP, Kraguljac NV, Keilhloz SD, Lahti AC. Aberrant static and dynamic functional patterns of frontoparietal control network in antipsychotic-naïve first-episode psychosis subjects. Human Brain Mapping. PMID 32372508 DOI: 10.1002/hbm.24992  1
2020 Nelson EA, Kraguljac NV, White DM, Jindal RD, Shin AL, Lahti AC. A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720904598. PMID 32022594 DOI: 10.1177/0706743720904598  1
2020 Roberts RC, McCollum LA, Schoonover KE, Mabry SJ, Roche JK, Lahti AC. Ultrastructural evidence for glutamatergic dysregulation in schizophrenia. Schizophrenia Research. PMID 32014360 DOI: 10.1016/j.schres.2020.01.016  1
2019 Maximo JO, Nelson EA, Armstrong WP, Kraguljac NV, Lahti AC. Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31902581 DOI: 10.1016/j.bpsc.2019.10.014  1
2019 Frölich MA, White DM, Kraguljac NV, Lahti AC. Baseline Functional Connectivity Predicts Connectivity Changes Due to a Small Dose of Midazolam in Older Adults. Anesthesia and Analgesia. PMID 31498189 DOI: 10.1213/ANE.0000000000004385  1
2019 Lottman KK, Gawne TJ, Kraguljac NV, Killen JF, Reid MA, Lahti AC. Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG. Neuroimage. Clinical. 24: 101959. PMID 31377556 DOI: 10.1016/j.nicl.2019.101959  1
2019 Allendorfer JB, Brokamp GA, Nenert R, Szaflarski JP, Morgan CJ, Tuggle SC, Ver Hoef L, Martin RC, Szaflarski BA, Kaur M, Lahti AC, Bamman MM. A pilot study of combined endurance and resistance exercise rehabilitation for verbal memory and functional connectivity improvement in epilepsy. Epilepsy & Behavior : E&B. 96: 44-56. PMID 31078935 DOI: 10.1016/j.yebeh.2019.04.020  1
2019 Kraguljac NV, Morgan CJ, Reid MA, White DM, Jindal RD, Sivaraman S, Martinak BK, Lahti AC. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Schizophrenia Research. PMID 30630705 DOI: 10.1016/j.schres.2018.12.028  1
2018 Nelson EA, White DM, Kraguljac NV, Lahti AC. Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment. Frontiers in Psychiatry. 9: 699. PMID 30618873 DOI: 10.3389/fpsyt.2018.00699  1
2018 Cadena EJ, White DM, Kraguljac NV, Reid MA, Maximo JO, Nelson EA, Gawronski BA, Lahti AC. A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia. Frontiers in Psychiatry. 9: 632. PMID 30555359 DOI: 10.3389/fpsyt.2018.00632  1
2018 Overbeek G, Gawne TJ, Reid MA, Salibi N, Kraguljac NV, White DM, Lahti AC. Relationship Between Cortical Excitation and Inhibition and Task-Induced Activation and Deactivation: A Combined Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study at 7T in First-Episode Psychosis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30470582 DOI: 10.1016/j.bpsc.2018.10.002  1
2018 Sivaraman S, Kraguljac NV, White DM, Morgan CJ, Gonzales SS, Lahti AC. Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients. Psychiatry Research. Neuroimaging. 281: 101-106. PMID 30286325 DOI: 10.1016/j.pscychresns.2018.06.003  1
2018 Cadena EJ, White DM, Kraguljac NV, Reid MA, Jindal R, Pixley RM, Lahti AC. Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia. Schizophrenia Research. PMID 30098853 DOI: 10.1016/j.schres.2018.07.045  1
2018 Cadena EJ, White DM, Kraguljac NV, Reid MA, Lahti AC. Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication. Npj Schizophrenia. 4: 8. PMID 29736018 DOI: 10.1038/s41537-018-0051-y  1
2018 Reid MA, Salibi N, White DM, Gawne TJ, Denney TS, Lahti AC. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. Schizophrenia Bulletin. PMID 29385594 DOI: 10.1093/schbul/sbx190  1
2018 Lottman KK, White DM, Kraguljac NV, Reid MA, Calhoun VD, Catao F, Lahti AC. Four-way multimodal fusion of 7 T imaging data using an mCCA+jICA model in first-episode schizophrenia. Human Brain Mapping. PMID 29315951 DOI: 10.1002/hbm.23906  1
2017 Harnett NG, Wood KH, Ference EW, Reid MA, Lahti AC, Knight AJ, Knight DC. Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms. Journal of Psychiatric Research. 91: 169-176. PMID 28478230 DOI: 10.1016/j.jpsychires.2017.04.010  1
2017 Lottman KK, Kraguljac NV, White DM, Morgan CJ, Calhoun VD, Butt A, Lahti AC. Risperidone Effects on Brain Dynamic Connectivity-A Prospective Resting-State fMRI Study in Schizophrenia. Frontiers in Psychiatry. 8: 14. PMID 28220083 DOI: 10.3389/fpsyt.2017.00014  1
2016 Gawne TJ, Killen JF, Tracy JM, Lahti AC. The effect of saccadic eye movements on the sensor-level magnetoencephalogram. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 128: 397-407. PMID 28142055 DOI: 10.1016/j.clinph.2016.12.013  1
2016 Cropsey KL, Clark CB, Stevens EN, Schiavon S, Lahti AC, Hendricks PS. Predictors of medication adherence and smoking cessation among smokers under community corrections supervision. Addictive Behaviors. 65: 111-117. PMID 27816035 DOI: 10.1016/j.addbeh.2016.10.010  1
2016 Kraguljac NV, Frölich MA, Tran S, White DM, Nichols N, Barton-McArdle A, Reid MA, Bolding MS, Lahti AC. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Molecular Psychiatry. PMID 27480494 DOI: 10.1038/mp.2016.122  1
2016 Hadley JA, Kraguljac NV, White DM, Ver Hoef L, Tabora J, Lahti AC. Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory. Npj Schizophrenia. 2: 16014. PMID 27336056 DOI: 10.1038/npjschz.2016.14  1
2016 Hammond JC, Lahti AC, Kraguljac NV. Rapid Clozapine Titration in an Acutely Agitated Patient With Schizoaffective Disorder: A Case Report. Journal of Clinical Psychopharmacology. PMID 26981924 DOI: 10.1097/JCP.0000000000000484  1
2016 Kraguljac NV, White DM, Hadley N, Hadley JA, Ver Hoef L, Davis E, Lahti AC. Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study. Schizophrenia Bulletin. PMID 26873890 DOI: 10.1093/schbul/sbv228  1
2016 Kraguljac NV, White DM, Hadley JA, Visscher K, Knight D, Ver Hoef L, Falola B, Lahti AC. Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone. Neuroimage. Clinical. 10: 146-58. PMID 26793436 DOI: 10.1016/j.nicl.2015.11.015  1
2016 Lahti AC. Making Progress Toward Individualized Medicine in the Treatment of Psychosis. The American Journal of Psychiatry. 173: 5-7. PMID 26725338 DOI: 10.1176/appi.ajp.2016.15101320  1
2015 White DM, Kraguljac NV, Reid MA, Lahti AC. Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study. Npj Schizophrenia. 1: 14001. PMID 26878032 DOI: 10.1038/npjschz.2014.1  1
2015 Reid MA, White DM, Kraguljac NV, Lahti AC. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia. Schizophrenia Research. PMID 26718333 DOI: 10.1016/j.schres.2015.12.003  1
2015 Libero LE, Reid MA, White DM, Salibi N, Lahti AC, Kana RK. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study. Autism Research : Official Journal of the International Society For Autism Research. PMID 26526126 DOI: 10.1002/aur.1562  1
2015 Roberts RC, Barksdale KA, Roche JK, Lahti AC. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophrenia Research. 168: 543-53. PMID 26210550 DOI: 10.1016/j.schres.2015.07.016  1
2015 Cropsey KL, Clark CB, Zhang XN, Hendricks PS, Jardin BF, Lahti AC. Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers. American Journal of Preventive Medicine. PMID 26091924 DOI: 10.1016/j.amepre.2015.03.014  1
2015 Bardeen JR, Stevens EN, Clark CB, Lahti AC, Cropsey KL. Cognitive risk profiles for anxiety disorders in a high-risk population. Psychiatry Research. PMID 26089016 DOI: 10.1016/j.psychres.2015.05.020  1
2015 Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM, Berens ME, Lahti AC, Nabors LB, Sontheimer H. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Science Translational Medicine. 7: 289ra86. PMID 26019222 DOI: 10.1126/scitranslmed.aaa8103  1
2015 Libero LE, DeRamus TP, Lahti AC, Deshpande G, Kana RK. Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 66: 46-59. PMID 25797658 DOI: 10.1016/j.cortex.2015.02.008  1
2015 Hutcheson NL, Sreenivasan KR, Deshpande G, Reid MA, Hadley J, White DM, Ver Hoef L, Lahti AC. Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication. Human Brain Mapping. 36: 1442-57. PMID 25504918 DOI: 10.1002/hbm.22714  1
2015 Skidmore FM, Spetsieris PG, Anthony T, Cutter GR, von Deneen KM, Liu Y, White KD, Heilman KM, Myers J, Standaert DG, Lahti AC, Eidelberg D, Ulug AM. A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls. Neuroinformatics. 13: 7-18. PMID 24974315 DOI: 10.1007/s12021-014-9222-9  1
2015 Roberts RC, Barksdale KA, Roche JK, Lahti AC. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia Schizophrenia Research. DOI: 10.1016/j.schres.2015.07.016  1
2014 Bolding MS, Lahti AC, White D, Moore C, Gurler D, Gawne TJ, Gamlin PD. Vergence eye movements in patients with schizophrenia. Vision Research. 102: 64-70. PMID 25088242 DOI: 10.1016/j.visres.2014.07.008  1
2014 Wheelock MD, Reid MA, To H, White DM, Cropsey KL, Lahti AC. Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings. Frontiers in Pharmacology. 5: 158. PMID 25071576 DOI: 10.3389/fphar.2014.00158  1
2014 Kraguljac NV, White DM, Hadley J, Reid MA, Lahti AC. Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia. Hippocampus. 24: 1524-32. PMID 25045047 DOI: 10.1002/hipo.22332  1
2014 Cropsey KL, Trent LR, Clark CB, Stevens EN, Lahti AC, Hendricks PS. How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 16: 1348-55. PMID 24891552 DOI: 10.1093/ntr/ntu085  1
2014 Cropsey KL, Leventhal AM, Stevens EN, Trent LR, Clark CB, Lahti AC, Hendricks PS. Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 16: 1174-82. PMID 24719492 DOI: 10.1093/ntr/ntu048  1
2014 Barksdale KA, Lahti AC, Roberts RC. Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2095-103. PMID 24603856 DOI: 10.1038/npp.2014.57  1
2014 Kraguljac NV, Cutter GR, Morgan C, Lahti AC. In reply. Jama Psychiatry. 71: 339-40. PMID 24599245 DOI: 10.1001/jamapsychiatry.2014.22  1
2014 Weller RE, Avsar KB, Cox JE, Reid MA, White DM, Lahti AC. Delay discounting and task performance consistency in patients with schizophrenia. Psychiatry Research. 215: 286-93. PMID 24388727 DOI: 10.1016/j.psychres.2013.11.013  1
2014 Hutcheson NL, Clark DG, Bolding MS, White DM, Lahti AC. Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry Research. 221: 6-12. PMID 24210948 DOI: 10.1016/j.pscychresns.2013.10.002  1
2014 Hadley JA, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, Visscher KM, Lahti AC. Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1020-30. PMID 24165885 DOI: 10.1038/npp.2013.305  1
2013 Kraguljac NV, Srivastava A, Lahti AC. Memory deficits in schizophrenia: a selective review of functional magnetic resonance imaging (FMRI) studies. Behavioral Sciences (Basel, Switzerland). 3: 330-47. PMID 25379242 DOI: 10.3390/bs3030330  1
2013 Avsar KB, Weller RE, Cox JE, Reid MA, White DM, Lahti AC. An fMRI investigation of delay discounting in patients with schizophrenia. Brain and Behavior. 3: 384-401. PMID 24381810 DOI: 10.1002/brb3.135  1
2013 Kraguljac NV, White DM, Reid MA, Lahti AC. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. Jama Psychiatry. 70: 1294-302. PMID 24108440 DOI: 10.1001/jamapsychiatry.2013.2437  1
2013 Reid MA, Kraguljac NV, Avsar KB, White DM, den Hollander JA, Lahti AC. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia. Schizophrenia Research. 147: 348-54. PMID 23706412 DOI: 10.1016/j.schres.2013.04.036  1
2013 Bolding MS, Reid MA, Avsar KB, Roberts RC, Gamlin PD, Gawne TJ, White DM, den Hollander JA, Lahti AC. Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biological Psychiatry. 73: 289-94. PMID 22981657 DOI: 10.1016/j.biopsych.2012.07.035  1
2012 Bolding MS, White DM, Hadley JA, Weiler M, Holcomb HH, Lahti AC. Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET. Frontiers in Psychiatry. 3: 105. PMID 23230425 DOI: 10.3389/fpsyt.2012.00105  1
2012 Bolding MS, Lahti AC, Gawne TJ, Hopkins KB, Gurler D, Gamlin PD. Ocular convergence deficits in schizophrenia. Frontiers in Psychiatry. 3: 86. PMID 23087652 DOI: 10.3389/fpsyt.2012.00086  1
2012 Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D, Lahti AC. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Research. 203: 111-25. PMID 22981426 DOI: 10.1016/j.pscychresns.2012.02.003  1
2012 Hutcheson NL, Reid MA, White DM, Kraguljac NV, Avsar KB, Bolding MS, Knowlton RC, den Hollander JA, Lahti AC. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophrenia Research. 140: 136-42. PMID 22831772 DOI: 10.1016/j.schres.2012.06.039  1
2012 Kraguljac NV, Reid MA, White DM, den Hollander J, Lahti AC. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2635-42. PMID 22805603 DOI: 10.1038/npp.2012.126  1
2012 Savage RM, Wiener HW, Nimgaonkar V, Devlin B, Calkins ME, Gur RE, O'Jile J, Bradford LD, Edwards N, Kwentus J, Allen T, McEvoy JP, Nasrallah H, Santos AB, Aduroja T, ... Lahti A, et al. Heritability of functioning in families with schizophrenia in relation to neurocognition. Schizophrenia Research. 139: 105-9. PMID 22627125 DOI: 10.1016/j.schres.2012.04.015  1
2011 Avsar KB, Stoeckel LE, Bolding MS, White DM, Tagamets MA, Holcomb HH, Lahti AC. Aberrant visual circuitry associated with normal spatial match-to-sample accuracy in schizophrenia. Psychiatry Research. 193: 138-43. PMID 21782395 DOI: 10.1016/j.pscychresns.2011.03.008  1
2011 Lahti AC, Reid MA. Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1779-80. PMID 21753798 DOI: 10.1038/npp.2011.83  1
2011 Somerville SM, Lahti AC, Conley RR, Roberts RC. Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response. Synapse (New York, N.Y.). 65: 215-24. PMID 20665724 DOI: 10.1002/syn.20838  1
2010 Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS, Knowlton RC, den Hollander JA, Lahti AC. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biological Psychiatry. 68: 625-33. PMID 20570244 DOI: 10.1016/j.biopsych.2010.04.013  1
2010 Hong LE, Summerfelt A, Buchanan RW, O'Donnell P, Thaker GK, Weiler MA, Lahti AC. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 632-40. PMID 19890262 DOI: 10.1038/npp.2009.168  1
2009 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2675-90. PMID 19675535 DOI: 10.1038/npp.2009.94  1
2009 Roberts RC, Roche JK, Conley RR, Lahti AC. Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response. Synapse (New York, N.Y.). 63: 520-30. PMID 19226604 DOI: 10.1002/syn.20623  1
2006 Artaloytia JF, Arango C, Lahti A, Sanz J, Pascual A, Cubero P, Prieto D, Palomo T. Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers American Journal of Psychiatry. 163: 488-493. PMID 16513871 DOI: 10.1176/appi.ajp.163.3.488  1
2006 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 221-30. PMID 16123774 DOI: 10.1038/sj.npp.1300837  1
2005 Parwani A, Weiler MA, Blaxton TA, Warfel D, Hardin M, Frey K, Lahti AC. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology. 183: 265-74. PMID 16220331 DOI: 10.1007/s00213-005-0177-2  1
2005 Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2275-82. PMID 16034443 DOI: 10.1038/sj.npp.1300824  1
2005 Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Research. 139: 19-30. PMID 15950442 DOI: 10.1016/j.pscychresns.2005.02.006  1
2005 LaPorte DJ, Blaxton TA, Michaelidis T, Robertson DU, Weiler MA, Tamminga CA, Lahti AC. Subtle effects of ketamine on memory when administered following stimulus presentation. Psychopharmacology. 180: 385-90. PMID 15719220 DOI: 10.1007/s00213-005-2179-5  1
2004 Holcomb HH, Parwani A, McMahon RP, Medoff DR, Frey K, Lahti AC, Tamminga CA. Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research. 127: 207-16. PMID 15296820 DOI: 10.1016/j.psychres.2004.04.003  1
2004 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 171-8. PMID 14520337 DOI: 10.1038/sj.npp.1300312  1
2003 Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Annals of the New York Academy of Sciences. 1003: 113-8. PMID 14684439 DOI: 10.1196/annals.1300.062  1
2003 Lahti AC, Holcomb HH. Schizophrenia, VIII: pharmacologic models. The American Journal of Psychiatry. 160: 2091. PMID 14638574 DOI: 10.1176/appi.ajp.160.12.2091  1
2003 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological Psychiatry. 53: 601-8. PMID 12679238 DOI: 10.1016/S0006-3223(02)01602-5  1
2002 Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. The American Journal of Psychiatry. 159: 1490-6. PMID 12202268 DOI: 10.1176/appi.ajp.159.9.1490  1
2001 Holcomb HH, Medoff DR, Lahti AC, Tamminga CA. Perceptual skill and brain physiology in subgroups of persons with schizophrenia. Dialogues in Clinical Neuroscience. 3: 294-5. PMID 22033645  1
2001 Tamminga CA, Lahti AC. Treatments for chronic psychosis. Dialogues in Clinical Neuroscience. 3: 281-92. PMID 22033485  1
2001 Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 11: 543-50. PMID 11732707 DOI: 10.1002/hipo.1070  1
2001 Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. The American Journal of Psychiatry. 158: 1797-808. PMID 11691685 DOI: 10.1176/appi.ajp.158.11.1797  1
2001 Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 455-67. PMID 11557159 DOI: 10.1016/S0893-133X(01)00243-3  1
2001 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Tamminga CA. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 165-72. PMID 11425500 DOI: 10.1016/S0893-133X(01)00229-9  1
2001 Lahti AC, Warfel D, Michaelidis T, Weiler MA, Frey K, Tamminga CA. Long-term outcome of patients who receive ketamine during research. Biological Psychiatry. 49: 869-75. PMID 11343683 DOI: 10.1016/S0006-3223(00)01037-4  1
2000 Weiler MA, Thaker GK, Lahti AC, Tamminga CA. Ketamine effects on eye movements. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 645-53. PMID 11063920 DOI: 10.1016/S0893-133X(00)00156-1  1
2000 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. The American Journal of Psychiatry. 157: 1634-45. PMID 11007718 DOI: 10.1176/appi.ajp.157.10.1634  1
2000 Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry. 57: 533-8. PMID 10839330 DOI: 10.1001/ARCHPSYC.57.6.533  1
2000 Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Research. Brain Research Reviews. 31: 364-70. PMID 10719164 DOI: 10.1016/S0165-0173(99)00053-3  1
1999 Angrist BM, Baldessarini RJ, Bowers MB, Buchanan RW, Caroff SN, Casey DE, Chouinard G, Cole JO, Conley RR, Csernansky J, Daniel D, Davidson M, Davis J, Davis KL, DeLisi L, ... ... Lahti AC, et al. Treatment of schizophrenia 1999 Journal of Clinical Psychiatry. 60: 3-80. PMID 10380713  1
1999 Lahti AC, Holcomb HH, Gao XM, Tamminga CA. NMDA-sensitive glutamate antagonism: A human model for psychosis Neuropsychopharmacology. 21: S158-S169. DOI: 10.1016/S0893-133X(99)00132-3  1
1998 Lahti AC, Weiler M, Carlsson A, Tamminga CA. Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 719-34. PMID 9826114 DOI: 10.1007/s007020050091  1
1998 Ross DE, Buchanan RW, Medoff D, Lahti AC, Thaker GK. Association between eye tracking disorder in schizophrenia and poor sensory integration. The American Journal of Psychiatry. 155: 1352-7. PMID 9766766  1
1998 Holcomb HH, Medoff DR, Caudill PJ, Zhao Z, Lahti AC, Dannals RF, Tamminga CA. Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers. Cerebral Cortex (New York, N.Y. : 1991). 8: 534-42. PMID 9758216 DOI: 10.1093/cercor/8.6.534  1
1998 Thaker GK, Ross DE, Cassady SL, Adami HM, LaPorte D, Medoff DR, Lahti A. Smooth pursuit eye movements to extraretinal motion signals: Deficits in relatives of patients with schizophrenia Archives of General Psychiatry. 55: 830-836. PMID 9736010 DOI: 10.1001/archpsyc.55.9.830  1
1998 Ross DE, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Compton AD, Thaker GK. The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia. Schizophrenia Research. 31: 141-50. PMID 9689718 DOI: 10.1016/S0920-9964(98)00027-9  1
1998 Ross DE, Thaker GK, Buchanan RW, Lahti AC, Conley R, Medoff D. Specific measures account for most of the variance in qualitative ratings of smooth pursuit eye movements in schizophrenia. Archives of General Psychiatry. 55: 184-6. PMID 9477936  1
1998 Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry. 43: 2-11. PMID 9442338 DOI: 10.1016/S0006-3223(97)00030-9  1
1998 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Kile L, Michaelidis T, Fletcher S, Tamminga CA. Time course of rCBF changes after acute haloperidol in patients with schizophrenia Neuroimage. 7: S245.  1
1997 Lahti RA, Lahti AC. Images in neuroscience. Clinical genetics, V. Association of genetic and personality characteristics. The American Journal of Psychiatry. 154: 1496. PMID 9356555  1
1997 Ross DE, Thaker GK, Buchanan RW, Kirkpatrick B, Lahti AC, Medoff D, Bartko JJ, Goodman J, Tien A. Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome. Biological Psychiatry. 42: 781-96. PMID 9347127 DOI: 10.1016/S0006-3223(96)00492-1  1
1996 Thaker GK, Ross DE, Buchanan RW, Moran MJ, Lahti A, Kim C, Medoff D. Does pursuit abnormality in schizophrenia represent a deficit in the predictive mechanism? Psychiatry Research. 59: 221-37. PMID 8930028 DOI: 10.1016/0165-1781(95)02759-9  1
1996 LaPorte DJ, Lahti AC, Koffel B, Tamminga CA. Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients. Journal of Psychiatric Research. 30: 321-30. PMID 8923336 DOI: 10.1016/0022-3956(96)00018-0  1
1996 Tamminga CA, Lahti AC. The new generation of antipsychotic drugs. International Clinical Psychopharmacology. 11: 73-6. PMID 8803664 DOI: 10.1097/00004850-199605002-00012  1
1996 Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley J. Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients. The American Journal of Psychiatry. 153: 1158-65. PMID 8780419  1
1995 Tamminga CA, Holcomb HH, Gao XM, Lahti AC. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. International Clinical Psychopharmacology. 10: 29-37. PMID 8866763  1
1995 Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 13: 9-19. PMID 8526975 DOI: 10.1016/0893-133X(94)00131-I  1
1995 Lahti AC, Tamminga CA. Recent developments in the neuropharmacology of schizophrenia. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 52: S5-8. PMID 7749964 DOI: 10.1093/ajhp/52.3_suppl_1.s5  1
1995 Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 6: 869-72. PMID 7612873  1
1995 Lahti RA, Lahti AC, Tamminga CA, Ranhosky, Kleber HD, Wise RA, Sethy. D2-family receptors in schizophrenia: Distribution and implications for treatment Clinical Neuropharmacology. 18: S110-S120.  1
1993 Thaker G, Adami H, Moran M, Lahti A, Cassady S. Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: High morbidity risks for unspecified functional psychoses and schizophrenia American Journal of Psychiatry. 150: 66-71. PMID 8417582  1
1991 Thaker GK, Ellsberry R, Moran M, Lahti A. Tobacco smoking increases square-wave jerks during pursuit eye movements Biological Psychiatry. 29: 82-88. PMID 2001447 DOI: 10.1016/0006-3223(91)90212-5  1
1990 Thaker GK, Moran M, Lahti A, Adami H, Tamminga C. Psychiatric Morbidity in Research Volunteers Archives of General Psychiatry. 47: 980. PMID 2222138 DOI: 10.1001/archpsyc.1990.01810220096020  1
1989 Thaker G, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga C. Oculomotor abnormalities and their clinical correlates in schizophrenia Psychopharmacology Bulletin. 25: 491-497. PMID 2626522  1
Show low-probability matches.